Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Immunoglobulin m monoclonal gammopathy of undetermined significance and smoldering Waldenström macroglobulinemia.

Kyle RA, Therneau TM, Dispenzieri A, Kumar S, Benson JT, Larson DR, Melton LJ 3rd, Rajkumar SV.

Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):184-6. doi: 10.1016/j.clml.2013.02.005. Epub 2013 Mar 13. Review.

2.

IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM).

Kyle RA, Dispenzieri A, Kumar S, Larson D, Therneau T, Rajkumar SV.

Clin Lymphoma Myeloma Leuk. 2011 Feb;11(1):74-6. doi: 10.3816/CLML.2011.n.011.

PMID:
21454195
3.

Survival in monoclonal gammopathy of undetermined significance and Waldenström macroglobulinemia.

Kristinsson SY, Björkholm M, Landgren O.

Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):187-90. doi: 10.1016/j.clml.2013.02.010. Epub 2013 Mar 13. Review.

PMID:
23490991
4.

Progression in smoldering Waldenstrom macroglobulinemia: long-term results.

Kyle RA, Benson JT, Larson DR, Therneau TM, Dispenzieri A, Kumar S, Melton LJ 3rd, Rajkumar SV.

Blood. 2012 May 10;119(19):4462-6. doi: 10.1182/blood-2011-10-384768. Epub 2012 Mar 26.

5.

IgM monoclonal gammopathy of undetermined significance and smoldering Waldenström's macroglobulinemia.

Kyle RA, Benson J, Larson D, Therneau T, Dispenzieri A, Melton Iii LJ, Rajkumar SV.

Clin Lymphoma Myeloma. 2009 Mar;9(1):17-8. doi: 10.3816/CLM.2009.n.002.

6.

Prevalence and prognosis implication of MYD88 L265P mutation in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia.

Correa JG, Cibeira MT, Tovar N, Isola I, Pedrosa F, Díaz T, Lozano E, Magnano L, Rosiñol L, Bladé J, Fernández de Larrea C.

Br J Haematol. 2017 Dec;179(5):849-851. doi: 10.1111/bjh.14266. Epub 2016 Sep 8. No abstract available.

PMID:
27605200
7.

Factors predicting transformation of asymptomatic IgM monoclonal gammopathy.

Greco A, Tedeschi A, Varettoni M, Nichelatti M, Paris L, Ricci F, Vismara E, Morra E.

Clin Lymphoma Myeloma Leuk. 2011 Feb;11(1):77-9. doi: 10.3816/CLML.2011.n.012.

PMID:
21454196
8.

Lymphoplasmacytic lymphoma and Waldenström macroglobulinemia.

Naderi N, Yang DT.

Arch Pathol Lab Med. 2013 Apr;137(4):580-5. doi: 10.5858/arpa.2012-0034-RS. Review.

PMID:
23544948
9.

Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors.

Varettoni M, Zibellini S, Capello D, Arcaini L, Rossi D, Pascutto C, Rattotti S, Mangiacavalli S, Pochintesta L, Gotti M, Gaidano G, Cazzola M.

Leuk Lymphoma. 2013 Nov;54(11):2485-9. doi: 10.3109/10428194.2013.779689. Epub 2013 Apr 17.

PMID:
23442064
10.

Long-term follow-up of IgM monoclonal gammopathy of undetermined significance.

Kyle RA, Therneau TM, Rajkumar SV, Remstein ED, Offord JR, Larson DR, Plevak MF, Melton LJ 3rd.

Blood. 2003 Nov 15;102(10):3759-64. Epub 2003 Jul 24.

11.
12.

Combination of serum microRNA-320a and microRNA-320b as a marker for Waldenström macroglobulinemia.

Kubiczkova Besse L, Sedlarikova L, Kryukov F, Nekvindova J, Radova L, Almasi M, Pelcova J, Minarik J, Pika T, Pikalova Z, Scudla V, Krejci M, Adam Z, Pour L, Hajek R, Sevcikova S.

Am J Hematol. 2015 Mar;90(3):E51-2. doi: 10.1002/ajh.23910. Epub 2015 Jan 16. No abstract available.

13.

Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system.

Baldini L, Goldaniga M, Guffanti A, Broglia C, Cortelazzo S, Rossi A, Morra E, Colombi M, Callea V, Pogliani E, Ilariucci F, Luminari S, Morel P, Merlini G, Gobbi P.

J Clin Oncol. 2005 Jul 20;23(21):4662-8.

PMID:
16034042
14.

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ 3rd.

N Engl J Med. 2002 Feb 21;346(8):564-9.

15.

Clinical practice. Monoclonal gammopathy of undetermined significance.

Bladé J.

N Engl J Med. 2006 Dec 28;355(26):2765-70. Review. No abstract available.

PMID:
17192542
16.

Differential diagnosis of monoclonal gammopathy of undetermined significance.

Merlini G, Palladini G.

Hematology Am Soc Hematol Educ Program. 2012;2012:595-603. doi: 10.1182/asheducation-2012.1.595. Review.

PMID:
23233640
17.
18.

Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders.

Morra E, Cesana C, Klersy C, Barbarano L, Varettoni M, Cavanna L, Canesi B, Tresoldi E, Miqueleiz S, Bernuzzi P, Nosari AM, Lazzarino M.

Leukemia. 2004 Sep;18(9):1512-7.

PMID:
15322559
19.

Waldenström macroglobulinemia.

Gertz MA.

Hematology. 2012 Apr;17 Suppl 1:S112-6. doi: 10.1179/102453312X13336169156212.

PMID:
22507796
20.

Monoclonal gammopathy of undetermined significance (MGUS).

Kyle RA.

Baillieres Clin Haematol. 1995 Dec;8(4):761-81. Review.

PMID:
8845571

Supplemental Content

Support Center